Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
July-2017 Volume 14 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2017 Volume 14 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

The mechanism of blood concentrations of the Shenqi pill repairing injured epithelial cells of renal tubular in vitro

  • Authors:
    • Fei Huang
    • Wenfeng Ma
  • View Affiliations / Copyright

    Affiliations: Department of Nephrology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei 445000, P.R. China, Department of Pharmacy, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei 445000, P.R. China
    Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 246-250
    |
    Published online on: May 11, 2017
       https://doi.org/10.3892/etm.2017.4450
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

In the present study, we investigated the best blood concentration of the mechanism of Shenqi pill repairing the injured epithelial cells of renal tubular in vitro. First, the injured hypoxia/reoxygenation model of rat proximal renal tubular epithelial cell strain (NRK-52E) was established. The animals were divided randomly into control, model, low concentration (5 µg/ml), moderate concentration (10 µg/ml) and high concentration (20 µg/ml) groups. The apoptotic rate was measured with flow cytometry and Jag2/Notch2/hes1 mRNA, and the protein expression was measured for 1, 3 and 7 days. It was found that in comparison to the control group, the growth of each group was prolonged with time, the levels of apoptosis, and the Jag2/Notch2/hes1 mRNA and protein expression decreased. Furthermore, the levels of the apoptotic rate, Jag2/Notch2/hes1 mRNA and protein expression of the moderate concentration and high concentration groups were significantly lower than those of the model and low‑dose groups at each time‑point (P<0.05). In conclusion, the Shenqi Pill alleviates the damage of renal tubular epithelial cells by inhibiting the Jag2/Notch2/hes1 signaling pathway; suitable concentration such as 10-20 µg/ml can exert protective effect.

Introduction

There is a higher incidence of acute kidney injury, for several reasons including ischemia and hypoxia, poisoning, infection, reperfusion, which may contribute to apoptosis or necrosis of renal tubular epithelial cells by the pathogenesis of inflammation, oxidative stress, calcium overload and metabolic disorders of energy (1,2). Notch2 can be widely expressed in the development process of kidney, and then turn silent when mature, and can be activated to participate in the disease process in a variety of external stimulation rapidly and largely such as sugar, in ischemia reperfusion injury (3). The Notch inhibitor DAPT (γ-inhibitor) has a protective effect on acute kidney injury (4). Jinguishenqi pill as an ancient prescription for tonifying kidney and kidney ‘qi’, (5,6) has better application effect in acute and chronic renal injury disease.

We analyzed the repairing mechanism of Shenqi pill in vitro on acute injury of renal tubular epithelial cells, to find the optimal blood concentration.

Materials and methods

Main materials and reagents

Rat proximal renal tubular epithelial cell strains (NRK-52E) were purchased from Cell Resource of Shanghai Institutes for Biological Sciences Center of Chinese Academy of Sciences Committee on Type Culture Collection Cell Bank (Shanghai, China). Dulbecco's modified Eagle's medium (DMEM)/F12 medium powder, trypsin (Gibco, Grand Island, NY, USA), high pure nitrogen of high-pressure (Shanxi Taiyuan Pharmaceutical Co., Ltd., Taiyuan, China), total RNA extraction kit, polymerase chain reaction (PCR) primers, TranScript cDNA first-strand synthesis kit, SYBR-Green I real-time PCR kits, pre-stained protein molecular weight marker (Beijing Zhongshan Science and Technology Co., Ltd., Beijing, China), ECL chemiluminescence kit (Pierce Biotechnology, Inc., Rockford, IL, USA), BCA protein assay kit (Kaiji Biological Technology Development Co., Ltd., Nanjing, China), rabbit anti-human Jag2/Notch2/hes1 and β-actin monoclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), horseradish peroxidase-labeled goat anti-rabbit IgG (Sigma-Aldrich, St. Louis, MO, USA) were purchased.

Main instruments

HEPA-CLASS 100 three gas tissue incubator (Thermo Fisher Scientific, Waltham, MA, USA), inverted microscope (Leica, Mannheim, Germany), ESP Elite flow cytometer (Beckman Coulter, Fullerton, CA, USA), micropipette (Eppendorf AG, Hamburg, Germany), SW-CJ-2FD type double-sided clean bench (Zhejiang Sujing Purification Equipment Co., Ltd., Sujing, China), TGL-16B high-speed desktop centrifuge (Shanghai Anting Scientific Instrument Factory, Shanghai, China), cell culture flasks, culture plates (Corning Inc., Acton, MA, USA), 721 spectrophotometer (Third Shanghai Analytical Instrument Factory, Shanghai, China), DYCZ-40D mini transfer electrophoresis and WD-9465B horizontal shaker (Beijing Liuyi Instrument Factory, Beijing, China).

Animal model of ischemia/reperfusion

Conventional recovery, culture, subculture, frozen storage, cells which had been passaged 2–3 times and reached to 80% cell confluence after replaced with serum-free DMEM/F12 medium for 24 h. The pure N2 was aerated continuously into oxygen-free liquid for 30 min in advance, to reach saturation. The three gas incubators were adjusted, and filled with 95% N2 + 1% O2 + 4% CO2. The cell culture medium was discarded, washed twice with phosphate-buffered saline (PBS) and incubated for hypoxia cultivation. It was followed by removal of liquid inside and oxygen-free liquid was added. Hypoxic cells were removed after 12 h, oxygen-free supernatants were collected and washed with the PBS, then added into complete DMEM/F12 medium. The cells were cultivated with reoxygenation in the three gas incubators adjusted to 95% air + 5% CO2, after 12 h cells and oxygen culture supernatant were collected.

Grouping

The animals were randomly divided into the control, model, low concentration (5 µg/ml), moderate concentration (10 µg/ml) and high concentrations (20 µg/ml) groups. After dissolving kidney pills in saline, the different concentration criterions were adjusted in terms of quality, experiment was co-cultured with 1 ml medicine. The control group was normal renal tubular epithelial cells, and the model group was applied with 1 ml saline. The apoptotic rate was measured with flow cytometry and Jag2/Notch2/hes1 mRNA as well as protein expression with quantitative PCR and western blot analysis detection, respectively, at 1, 3 and 7 days. Five samples were selected at each time-point, and results are the average values.

Detection of cell apoptosis by flow cytometry

The NRK-52E cells were seeded into six pore plates in accordance with 5×105 cells/pore density. The pancreatic cells (200 µl) were added and centrifuged for 5 min at 800 × g. The supernatant was discarded; washed with pre-cold PBS and centrifuged for 5 min at 800 × g, and was repeated twice, followed by removal of the supernatant. Subsequently, 500-µl binding buffer suspension cells were added, 5 µl Annexin V-FITC was added and mixed well. The cells were then incubated for 15 min at 4°C, and 5 µl PI was added to homogenize the content in the dark at room temperature for 5–15 min, before detection within 1 h.

Quantitative PCR detection

Conventional TRIzol extraction of total RNA, spectrophotometer purity and concentration, led to the production of cDNA. The primer sequences were: Jag2 forward, 5′-TGTGGTTGGAAGCCTTGTCTG-3′ and reverse, 5′-TGTCCAAATGAGTGGTCCGT-3′; Notch2 forward, 5′-CACCAACTTACGCATTAAACAAGAC-3′ and reverse, 5′-TCCGATTCACTGACAACAGACAC-3′; hes1 forward, 5′-TGCTTTCCTCATCCCCAATG-3′ and reverse, 5′-GAAGGCGACACTGCGTTAGG-3′; the internal control β-actin forward, 5′-CGTTGACATCCGTAAAGACCTC-3′ and reverse, 5′-TAGGAGCCAGGGCAGTAATCT-3′. The reaction system consisted of cDNA (5 µl), target gene downstream primer (100 pmol/l, 2 µl), 10X buffer (2.5 µl), 10 mmol dBTPs (3 µl), Taq enzyme (1 µl), ultra-pure water to total volume of 25 µl. The reaction parameters included denaturation at 95°C for l min, 95°C for 15 sec, 58°C for 20 sec, 72°C for 20 sec for 40 cycles in total, and a final extension at 72°C for 5 min. The final solubility curve results were expressed in the ratio of the target gene and reference gene, using the 2−∆∆Cq formula.

Western blot assay

Total protein was extracted and quantified with Bradford assay. Western blotting was performed as described elsewhere (7). The primary antibody was used for incubation overnight at 4°C. The following day, the membrane was washed three times with TBST at room temperature and the secondary antibody diluted with TBST 3,000 times, was used for incubation at room temperature 30 min. It was then washed three times with TBST at room temperature. Subsequently, the chemiluminescence reaction was used for developing the protein images. Rabbit polyclonal JAG2 antibody (dilution, 1:500; cat. no. ab109627), rabbit polyclonal Notch2 antibody (dilution, 1:500; cat. no. ab8926), rabbit polyclonal Hes1 antibody (dilution, 1:500; cat. no. ab71559) and secondary goat anti-rabbit (HRP) IgG antibody (dilution, 1/2000; cat. no. ab6721) were all purchased from Abcam (Cambridge, MA, USA).

Statistical analysis

SPSS 19.0 (Chicago, IL, USA) was used to analyze the data. Quantitative data are shown as mean ± standard deviation, the comparison among groups was shown by using single-factor ANOVA analysis, while repeated measures analysis of variance was applied in the intra-group. Qualitative data were compared with the number of cases or percentage (%), χ2 test was used among groups. P<0.05 was considered to indicate a statistically significant difference.

Results

Comparison of the rate of apoptosis

In addition to the control group, the other groups took longer to grow. The apoptotic rate decreased and at each time-point of the moderate concentration and high concentration groups was significantly lower than that of the model and low concentration groups (P<0.05) (Table I and Fig. 1).

Figure 1.

Cell apoptotic rate by flow cytometry. (A) Control, (B) model, (C) low concentration, (D) moderate concentration and (E) high concentration groups.

Table I.

Comparison of cell apoptosis rate (%).

Table I.

Comparison of cell apoptosis rate (%).

Groups1 day3 days7 days
Control   0.3±0.1   0.2±0.1   0.2±0.1
Model26.5±4.224.2±3.520.1±3.2
Low concentration21.4±4.020.2±3.615.5±3.2
Moderate concentration13.2±3.37.5±2.03.4±1.1
High concentraition13.3±3.47.6±2.23.5±1.3
F-value7.5249.62312.522
P-value<0.001<0.001<0.001
Comparison of mRNA Jag2/Notch2/hes1 expression levels

In addition to the control group, the other groups were grown with extension of time. The mRNA Jag2/Notch2/hes1 expression levels decreased and the expression levels of the mRNA Jag2/Notch2/hes1 of the concentration and high concentration group at each time-point was significantly lower than that of the model and low-dose groups, and the difference was significant (P<0.05) (Table II and Fig. 2).

Figure 2.

Detection of quantitative PCR method comparison of mRNA Jag2/Notch2/hes1 expression levels.

Table II.

Comparison of mRNA Jag2/Notch2/hes1 expression levels.

Table II.

Comparison of mRNA Jag2/Notch2/hes1 expression levels.

Jag2Notch2hes1



Groups1 day3 days7 days1 day3 days7 days1 day3 days7 days
Control0.06±0.020.05±0.010.05±0.020.04±0.010.03±0.010.03±0.010.03±0.010.02±0.010.03±0.01
Model0.42±0.060.33±0.040.28±0.040.36±0.040.30±0.030.26±0.030.34±0.030.30±0.030.25±0.03
Low concentration0.40±0.050.30±0.050.25±0.030.33±0.030.27±0.040.24±0.030.31±0.030.27±0.030.22±0.03
Moderate concentration0.32±0.040.26±0.030.19±0.030.26±0.030.20±0.020.13±0.020.25±0.030.18±0.030.12±0.03
High concentration0.33±0.040.28±0.040.21±0.040.27±0.030.21±0.030.15±0.020.25±0.030.20±0.030.13±0.03
F-value6.5296.9677.4217.2017.4247.6256.9386.8577.203
P-value<0.001<0.001<0.001<0.001<0.001<0.001<0.001<0.001<0.001
Comparison of Jag2/Notch2/hes1 protein expression levels

In addition to the control group, the other groups took longer to grow. The Jag2/Notch2/hes1 protein expression levels decreased and the Jag2/Notch2/hes1 protein expression levels of concentration and high concentration group at each time-point was significantly lower than that of the model group and low-dose group (P<0.05) (Table III and Fig. 3).

Figure 3.

Jag2/Notch2/hes1 protein expression levels detected by western blot analysis.

Table III.

Comparison of Jag2/Notch2/hes1 protein expression levels.

Table III.

Comparison of Jag2/Notch2/hes1 protein expression levels.

GroupsJag2Notch2hes1



1 day3 days7 days1 day3 days7 days1 day3 days7 days
Control0.06±0.020.05±0.010.05±0.020.04±0.010.03±0.010.03±0.010.03±0.010.02±0.010.03±0.01
Model0.48±0.070.41±0.060.36±0.060.39±0.050.32±0.040.28±0.040.36±0.040.32±0.040.27±0.03
Low concentration0.44±0.050.39±0.060.33±0.050.35±0.040.30±0.040.26±0.050.33±0.040.29±0.030.24±0.04
Moderate concentration0.35±0.040.28±0.050.20±0.040.28±0.040.22±0.030.15±0.030.26±0.040.19±0.040.15±0.03
High concentration0.36±0.040.29±0.060.21±0.050.29±0.040.21±0.050.16±0.030.27±0.050.20±0.030.15±0.04
F-value7.2317.3457.6267.5287.7177.9628.2318.4658.721
P-value<0.001<0.001<0.001<0.001<0.001<0.001<0.001<0.001<0.001

Discussion

Notch signaling pathway is a major signaling pathway, which mediates the direct contact between the cells and also plays an important role in the regulation of cell growth, differentiation, tissue regeneration and the stability of intracellular environment. The Notch family consists of a group of highly conserved proteins including four cognate receptor Notch l-4, 5 types of homolog ligand Delta-like 1, 3 and 4, and Jagged 1 and 2, and two types of downstream target genes: The Hes and Hey families. When tissue is subjected to hypoxia and drug damage, the activation of ligand expression would increase, which can result in the series of proteolytic cleavage of Notch receptors via the Notch receptor binding through cell to cell contact, and then release the Notch intracellular domain of activity; the Notch intracellular domain activity is transferred to the cell nucleus and combined with the transcription factor binding, starting the transcription of the target gene, regulating and controlling the cell proliferation (7,8).

The Jinguishenqi pill is composed of 8 g Rehmannia, jujube peel, 4 g Chinese yam, 3 g each of Alisma, paeonol, Poria cocos and Cassia twig, and 1 g aconite. The original description: ‘Rehmannia is sweet-warm, enriching yin and nourishing the kidney as the main drug, supplemented by acid tepid dogwood, nourishing liver and kidney, protecting vital essence with astringency; yam was sweet taste and neutral nature, good at strengthening spleen and tonifying kidney; plus a small amount of aconite and cinnamon which could warm kidney and enhance Yangqi, fill Mingmen real fire, conduct the fire back to its origin; accompanied with plantain regulating the waterways, draining water evil in renal; tuckahoe tonifying spleen, clearing damp and promoting diuresis; cortex mouton clearing liver fire’, in various drug combinations (9,10). The study indicated that in addition to the control group, each group grew for a longer time. The levels of apoptosis rate, Jag2/Notch2/hes1 mRNA and protein expression decreased and the levels of apoptosis, Jag2/Notch2/hes1 mRNA and protein expression of concentration and high concentration group were obviously lower than those of the model group and low dose group at each time-point, the difference was statistically significant. Glomerular apoptosis rate reached the peak when acute kidney injury occurred, and then decreased gradually. Jag2/Notch2/hes1 mRNA and protein expression levels were also decreased, these changes suggested that early intervention of acute kidney injury could reduce the extent of tissue damage, and be conducive to regeneration of tissue (11). Shenqi Pill could relieve the damage of renal tubular epithelial cells by inhibiting the activation and expression of Jag2/Notch2/hes1 signaling pathway. The different concentrations had different effects, low concentration slightly inhibited Jag2/Notch2/hes1 mRNA and protein expression, a suitable concentration such as 10–20 g/ml could play a better supporting effect. The specific reasons for not getting improved effects by the increase of the concentration should be further analyzed.

The present study has confirmed the inhibitory effects of Shenqi Pill on Jag2/Notch2/hes1 signaling pathway by experiments in vitro. As the Shenqi pill is a compound drug, it was not possible to determine the specific components which played a major role. Application effects can be further explored in in vivo animal experiments or clinical studies.

References

1 

Gao Y, Zeng Z, Li T, Xu S, Wang X, Chen Z and Lin C: Polydatin inhibits mitochondrial dysfunction in the renal tubular epithelial cells of a rat model of sepsis-induced acute kidney injury. Anesth Analg. 121:1251–1260. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Li K, Han Q, Yan X, Liao L and Zhao RC: Not a process of simple vicariousness, the differentiation of human adipose-derived mesenchymal stem cells to renal tubular epithelial cells plays an important role in acute kidney injury repairing. Stem Cells Dev. 19:1267–1275. 2010. View Article : Google Scholar : PubMed/NCBI

3 

Cheng HT and Kopan R: The role of Notch signaling in specification of podocyte and proximal tubules within the developing mouse kidney. Kidney Int. 68:1951–1952. 2005. View Article : Google Scholar : PubMed/NCBI

4 

Huang R, Zhou Q, Veeraragoo P, Yu H and Xiao Z: Notch2/Hes-1 pathway plays an important role in renal ischemia and reperfusion injury-associated inflammation and apoptosis and the γ-secretase inhibitor DAPT has a nephroprotective effect. Ren Fail. 33:207–216. 2011. View Article : Google Scholar : PubMed/NCBI

5 

Nan Y, Zhou X, Liu Q, Zhang A, Guan Y, Lin S, Kong L, Han Y and Wang X: Serum metabolomics strategy for understanding pharmacological effects of ShenQi pill acting on kidney yang deficiency syndrome. J Chromatogr B Analyt Technol Biomed Life Sci. 19:102–103. 2015.

6 

Xiong X, Wang P, Li X and Zhang Y: Shenqi pill, a traditional Chinese herbal formula, for the treatment of hypertension: a systematic review. Complement Ther Med. 23:484–493. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Kramer J, Schwanbeck R, Pagel H, Cakiroglu F, Rohwedel J and Just U: Inhibition of Notch signaling ameliorates acute kidney failure and downregulates platelet-derived growth factor receptor β in the mouse model. Cells Tissues Organs. 201:109–117. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Juillerat-Jeanneret L, Flohr A, Schneider M, Walter I, Wyss JC, Kumar R, Golshayan D and Aebi JD: Targeted γ-secretase inhibition to control the Notch pathway in renal diseases. J Med Chem. 58:8097–8109. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Long YL and Li ZM: Effect of jingui shenqi pill and its disassembled recipes on ovarian functions in shen yang deficiency female rats. Zhongguo Zhong Xi Yi Jie He Za Zhi. 33:967–971. 2013.(In Chinese). PubMed/NCBI

10 

Xu CP, Zhu QJ, Song J, Li Z and Zhang D: Acceleration of Jingui Shenqi Pill on the testis telomerase activity in mice of Shen-yang deficiency. Zhongguo Zhong Xi Yi Jie He Za Zhi. 33:252–255. 2013.(In Chinese). PubMed/NCBI

11 

Sörensen-Zender I, Rong S, Susnik N, Zender S, Pennekamp P, Melk A, Haller H and Schmitt R: Renal tubular Notch signaling triggers a prosenescent state after acute kidney injury. Am J Physiol Renal Physiol. 306:F907–F915. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Huang F and Ma W: The mechanism of blood concentrations of the Shenqi pill repairing injured epithelial cells of renal tubular in vitro. Exp Ther Med 14: 246-250, 2017.
APA
Huang, F., & Ma, W. (2017). The mechanism of blood concentrations of the Shenqi pill repairing injured epithelial cells of renal tubular in vitro. Experimental and Therapeutic Medicine, 14, 246-250. https://doi.org/10.3892/etm.2017.4450
MLA
Huang, F., Ma, W."The mechanism of blood concentrations of the Shenqi pill repairing injured epithelial cells of renal tubular in vitro". Experimental and Therapeutic Medicine 14.1 (2017): 246-250.
Chicago
Huang, F., Ma, W."The mechanism of blood concentrations of the Shenqi pill repairing injured epithelial cells of renal tubular in vitro". Experimental and Therapeutic Medicine 14, no. 1 (2017): 246-250. https://doi.org/10.3892/etm.2017.4450
Copy and paste a formatted citation
x
Spandidos Publications style
Huang F and Ma W: The mechanism of blood concentrations of the Shenqi pill repairing injured epithelial cells of renal tubular in vitro. Exp Ther Med 14: 246-250, 2017.
APA
Huang, F., & Ma, W. (2017). The mechanism of blood concentrations of the Shenqi pill repairing injured epithelial cells of renal tubular in vitro. Experimental and Therapeutic Medicine, 14, 246-250. https://doi.org/10.3892/etm.2017.4450
MLA
Huang, F., Ma, W."The mechanism of blood concentrations of the Shenqi pill repairing injured epithelial cells of renal tubular in vitro". Experimental and Therapeutic Medicine 14.1 (2017): 246-250.
Chicago
Huang, F., Ma, W."The mechanism of blood concentrations of the Shenqi pill repairing injured epithelial cells of renal tubular in vitro". Experimental and Therapeutic Medicine 14, no. 1 (2017): 246-250. https://doi.org/10.3892/etm.2017.4450
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team